ARCHIVES

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 40 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013